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Traumatic brain injury (TBI) is one of the most important death and disability cause, involving 
substantial costs, also in economic terms, when considering the young age of the involved subject. Aim 
of this paper is to report a series of patients treated at our institutions, to verify neurological results 
at six months or survival; in fatal cases we searched for βAPP, GFAP, IL-1β, NFL, Spectrin II, TUNEL 
and miR-21, miR-16, and miR-92 expressions in brain samples, to verify DAI diagnosis and grade as 
strong predictor of survival and inflammatory response. Concentrations of 8OHdG as measurement of 
oxidative stress was performed. Immunoreaction of β-APP, IL-1β, GFAP, NFL, Spectrin II and 8OHdG 
were significantly increased in the TBI group with respect to control group subjects. Cell apoptosis, 
measured by TUNEL assay, were significantly higher in the study group than control cases. Results 
indicated that miR-21, miR-92 and miR-16 have a high predictive power in discriminating trauma brain 
cases from controls and could represent promising biomarkers as strong predictor of survival, and for 
the diagnosis of postmortem traumatic brain injury.
Traumatic brain injury (TBI) is a group of complex lesions involving the brain and able to determine an alteration 
in the normal brain function, that occurs as a result of a shock, a blow or a shock or following a head penetrating 
trauma1. In this definition are therefore some conditions that have a different timing of onset (acute or chronic), 
such as to include under the term TBI different conditions as brain concussion, chronic traumatic encephalopa-
thy, diffuse axonal injury. Each of this conditions occupies a prominent role both in the causes of death statistics, 
and in physical and mental disability statistics.
It is often difficult discriminate type of damage since the artefacts found at macroscopic and microscopic 
examination because are often overlapping, in some cases non-specific as it is often possible to find an overlap of 
pathogenetic mechanisms that do not allow or make it very difficult to distinguish between the primary damage 
due to trauma and secondary consequences of the same2.
Clinical classification of TBI takes into account symptoms severity, evaluated with GCS score3, so for which 
may be divided into:
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•	 Mild TBI when the GCS is between 13 and 15, there has been a significant retrograde amnesia (<1 day), loss 
of consciousness was short (<30 minutes);
•	 Moderate TBI when GCS is between 9 and 12, 1–7 days of retrograde amnesia, loss of consciousness lasts 
between 30 minutes and 24 hours;
•	 Severe TBI when GCS is between 3–8, retrograde amnesia more than 7 days and loss of consciousness > 24 h.
One of the simplest classification takes in consideration trauma extension that can have a focal trauma (tear-
ing or bruising, haemorrhage, secondary focal lesions with increased intracranial pressure), multifocal or diffuse 
involvement (DAI, global ischemia, diffuse cerebral edema)4.
Another forensic classification divides TBI into:
•	 Impact injuries are invariably associated with situations where the head hurt with an object;
•	 Acceleration–deceleration brain injury resulting from unrestricted movement of the head;
•	 Compressive strains or penetranting injuries when an object passes through the skull and causing directly 
parenchymal injury.
TBI have a significant health economic relevance, because in spite of a slight variation in incidence rates in 
different countries, it is believed interests around 200–300 over 100,000 people5.
In the USA, CDC has indeed estimated that about 50,000 deaths each year are as a direct consequence of TBI, 
and a much larger number of individuals develop a more or less severe disabilities6.
In Europe the incidence rate is almost the same between each European country, and it is estimated that 
approximately 7 million people have developed a disability as a result of TBI3,7.
The high incidence of TBI and considerable repercussions on the mortality rates of disability, is an important 
issue in social, health and economics fields8–17.
Traumatic brain injury, despite covering different pathological forms, can be traced into two different patho-
genetic pathways though partly overlapping each other and fall into two basic underlying mechanisms: a primary 
damage that is a consequence of destruction of brain tissue with possible axonal shearing and a secondary damage 
that is a consequence of activation of cellular and molecular pathways such as apoptosis, inflammation and dis-
ruption of Blood Brain Barrier (BBB) that can be followed by vasogenic or extracellular edema18,19.
Axonal damage can be a consequence of collapse and stretching of the axonal plasma membrane resulting in 
major dysregulation of ionic transcellular exchange with neuronal depolarization and increased pump activities20. 
Simultaneous activation of multiple intracellular signaling pathways lead activation of immediate transcriptional 
factors (c-fos, c-jun), that regulate expression of a variety of target genes (growth factors, cytoskeletal proteins, 
heat-shock proteins (HSPs)21,22.
The structural features of DAI were defined by Adams et al. using a series of 45 fatal cases23.
In its most severe form, DAI has three distinctive structural features:
 1. Diffuse supratentorial damage to axons (grade I)
 2. A focal lesion in the corpus callosum (grade II)
 3. A focal lesion or lesions in the rostral brain stem (grade III)24.
Traumatic insult determines in the first instance a considerable increase in the levels of mediators capable of 
exerting an action on excitotoxicity on neuronal structures such as glutamate. Increased production of free rad-
icals highly reactive can also damage DNA, in addition to direct neurotoxic action due to lipoperoxidation and 
consequent neuronal membrane damage25.
Aim of this paper is to report a series of patients treated at our institutions, to verify neurological results 
at six months or survival; in fatal cases we searched for β-APP, IL-1β, GFAP, NFL, Spectrin II, 8OHdG, 
TUNEL and miR-21, miR-16, and miR-92 expressions in brain samples, to verify DAI diagnosis, and grade 
as strong predictor of survival and inflammatory response. We searched immunohistochemical expression of 
8-hydroxy-2-deoxyguanosine (8OHdG) which is an oxidized derivative of deoxyguanosine. 8-Oxo-dG is one of 
the major products of DNA oxidation. Concentrations of 8OHdG within a cell are a measurement of oxidative 
stress26. The selection of miRNAs candidates was made by searching in available literature for traumatic brain 
injury-specific miRNAs which should also be expressed post mortem. The vast majority of scientific reports 
dealing with traumatic brain injury employs murine models27,28. Concerning studies on humans, most of them 
are based on cell lines or biological fluids, such as plasma and serum29,30. On the contrary, our work deals with 
paraffin-embedded brain sections.
To our knowledge, this is the first experimental study documenting the differently expressions of miRNAs in 
paraffin-embedded sections of subjects with complex traumatic brain injury with respect to controls.
Results
Sex did not affect neurological results at six months (GOS) or survival. DAI grade was a strong predictor of sur-
vival and presented an association with GOS at six months (p.002; p.065 respectively) (Fig. 1A-A1). The specific 
mechanism of trauma did not affect GOS or survival. Similarly, the multiple trauma in place of a predominantly 
head trauma did not predict, in this cohort, a worse neurological outcome or survival. The diagnosis of MOF 
was a predictor of lesser survival and worse GOS outcome (p.018; p.049 respectively); uncontrolled hypotension 
disclosed similar statistical association (p.010; p.059 respectively) (Fig. 1A-A1,B-B1).
Decompressive craniectomy had a significant impact on GOS at 6 months (p.015) in respect to conservative 
treatment or just ventriculostomy, but not on survival (Fig. 1C-C1). We furthermore performed a Kaplan-Meier 
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analysis to retrieve survival differences among the different subgroups (Fig. 2). Such analysis completely con-
firmed the survival advantage for the patients suffering from a lower DAI grading and not experiencing uncon-
trolled hypotension.
The histological and immunohistochemical characteristics of the study group compared to the control group 
are shown in Table 1.
Semi-quantitative evaluation (grade 0–4) revealed increased immunoreaction of β-APP in TBI cases (Fig. 3A). 
GFAP expression was significantly increased in the TBI group with respect to control group subjects whose death 
Figure 1. Impact of DAI grading, hypotension and surgery on GOS. Impact of DAI grading and hypothension 
on (A-A1) GOS at 6 months and (B-B1) survival. Impact of surgery on (C-C1) GOS at 6 months.
Figure 2. Kaplan-Meier analysis, comparing DAI and hypothension subgroups. The analysis confirms 
advantage for the patients suffering from a lower DAI grading and not experiencing uncontrolled hypotension.
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was from other causes (Fig. 3B). Intense IL-1β immunoreaction in the TBI group matched by the negative marker 
of expression in the control group (Fig. 3C). Apoptosis was measured by TUNEL assay and values of cell apop-
tosis in the study group were significantly higher than control cases. The apoptotic nuclei appeared isolated or 
irregularly distributed over the entire brain section. The percentage of apoptotic nuclei was determined. The 
Control group TBI group Thalamus Hypothalamus Striatum Statistical value TBI vs Control
anti-β-APP +/− +++ +++ +++ +++ *** p < 0.001
IL-1β − +++ +++ +++ +++ *** p < 0.001
Anti-GFAP +/− +++ +++ +++ +++ *** p < 0.001
TUNEL assay +/− +++ +++ +++ +++ *** p < 0.001
Anti-NFL + +++ +++ +++ +++ *** p < 0.001
Anti-Spectrin II +/− +++ +++ +++ +++ *** p < 0.001
Anti-8OHdG +/− +++ +++ +++ +++ *** p < 0.001
Table 1. Statistical analysis of the immunohistochemical findings and gradation of the immunohistochemical 
reactions. Responses about antibody anti-β-APP, IL-1β, anti-GFAP, anti-NFL, anti-Spectrin II, anti-8OHdG 
and TUNEL assay expressions in brain specimens (thalamus, hypothalamus and striatum). NS: p > 0.05; 
* p < 0.05; ** p < 0.01; *** p < 0.001. Intensity of immunopositivity was assessed semiquantitatively in the 
scale 0–4 as follows: −: no immunoreactivity (0%); +: mild immunopositivity in scattered cells (10%); ++: 
immunopositivity in up to one third of cells (33%); +++: immunopositivity in up to two- third of cells (70%) 
and ++++: strong immunopositivity in the majority or all cells (100%). In cases of divergent scoring, a third 
observer decided the final category.
Figure 3. Immunohistochemical reactions for anti-β-APP, anti-IL-1β, anti-GFAP and TUNEL assay. (A) 
Anti-β-APP reaction was prominent in the axonal bulbs and fibers of the affected regions in the TBI group. 
Insert represents normal reactions from control group. (B) Reaction to IL-1β was intensely positive mainly in 
neurons. Insert represents normal reactions from control group. (C) In acute cases a diffuse anti-GFAP reaction 
was evident in sporadic fields. Insert represents normal reactions from control group. (D) The apoptotic nuclei 
(arrows) appeared isolated or irregularly distributed over the entire brain section. (Insert) Confocal laser 
scanning microscope: typical morphological features of neuronal (green) apoptosis (arrows) associated with 
marked condensation of chromatin and its fragmentation into discrete bodies (yellow). Insert represents normal 
reactions from control group.
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immunohistochemical study revealed an intensive positive result to TUNEL assay (Fig. 3D): 60 ± 13% and 7 ± 1% 
apoptotic cells were observed in TBI group and control group, respectively.
Statistical analysis of the immunohistochemical findings and gradation of the immunohistochemical reactions 
are summarized in Fig. 4.
Also anti-spectrin II and NFL reactions were intensely positive mainly in TBI neurons, compared to control 
group (Fig. 5). While 8OHdG immunoreactivity was detected in very few cells of the frontal cortex of control 
group, a significant elevation of the number of 8OHdG positive cells was observed in subjects died following TBI 
(Fig. 6).
To assess the ability of each miRNA to discriminate between samples and controls, receiver-operating charac-
teristic (ROC) curves were built and the areas under the curve (AUCs) were calculated (Fig. 7A–D). Univariate 
analysis for each miRNA led an AUC of 0.79 (95% CI = 0.57–1.01, p = 0.03) for miR-21 (Fig. 7A), an AUC of 0.79 
(95% CI = 0,57–1,01 p = 0.029) for miR-16 (Fig. 7B) and AUC of 0.89 (95% CI = 0.73–1.04 p = 0.003) for miR-92 
(Fig. 7C). A multivariate analysis was performed combining the three miRNAs and gave an AUC of 0.85 (95% 
CI = 0.66–1,04, p = 0.008) (Fig. 7D).
These data indicate that these three miRNAs have a high predictive power in discriminating trauma brain 
cases from controls and could represent promising biomarkers for the diagnosis of postmortem traumatic brain 
injury. In particular, the expression of miR-21 was three times higher in controls than subjects who died for trau-
matic brain injury (Fig. 8).
Discussion
Pathological diagnosis of brain injury can be difficult in some cases or can leave diagnostic doubts, especially in 
cases of mild given, or in cases when instrumental examinations are negative, or macroscopic examination does 
not always allow to appreciate evident alterations, as in the case of DAI where the diagnosis is today possible only 
through in-depth instrumental analysis.
For these reasons the search for blood markers that can assist clinicians in diagnosis and staging of TBI and 
immunohistochemical markers that can help pathologist in evaluation of traumatic brain injury and survival time 
interval estimation has always aroused considerable interest.
In the present work, we searched for a panel of selected traumatic brain injury-specific miRNAs differently 
expressed in brain sections of subjects who died for traumatic brain injury and control group. The selection of 
miRNAs candidates was made by searching in available literature for traumatic injury-specific miRNAs which 
Figure 4. Statistical analysis of the immunohistochemical findings and gradation of the immunohistochemical 
reactions. Responses about antibody (A) anti-β-APP, (B) IL-1β, (C) anti-GFAP and (D) TUNEL assay 
expressions in brain specimens (thalamus, hypothalamus and striatum).
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should also be expressed post mortem. The vast majority of scientific reports dealing with traumatic brain injury 
employs murine models27,28. Concerning studies on humans, most of them are based on cell lines or biological 
fluids, such as plasma and serum29–31. On the contrary, our work deals with paraffin-embedded brain sections. To 
our knowledge, this is the first report documenting the downregulation of miR-21 in paraffin-embedded sections 
of subjects with complex traumatic brain injury with respect to controls. In particular, the expression of miR-21 
was three times higher in controls than subjects who died for traumatic brain injury.
However, several miRNA profiling studies using biological and functional approaches on TBI were per-
formed32–36 to dissect the role miRNAs significantly altered in TBI. Concerning in vitro studies, Bhalala et al. 
reported the increased miR-21 expression following spinal cord injury correlate with astrocyte hypertrophy, 
which represents an event associated with TBI37. These facts, together with the evidence that miR-21 is able 
to promote axon growth, led researchers to hypothesize a role for miR-21 as a neuroprotective molecule in 
TBI38,39. Another study on murine astrocytes and neuronal cells reported temporal differences in a pattern of 
miRNAs after ischemia: miR-21 was upregulated at 12 h and at 24 h post-OGD (oxygen-glucose deprivation) as 
compared to expression in control neurons. In astrocytes undergoing OGD, miR-21 levels increased only 12 h 
after OGD (1.6 > fold, p < 0.05)27. Similarly, Ge and colleagues found an increased expression of miR-21 in rat 
brains after traumatic brain injury (TBI). They hypothesized this could protect against blood-brain barrier (BBB) 
Figure 5. Immunohistochemical reactions for anti-spectrin II and NFL with statistical analysis of the 
immunohistochemical findings and gradation of the reactions. (A) Anti-spectrin II reaction was intensely 
positive mainly in TBI neurons, compared to control group (B), as reported (C). NFL expression was 
significantly increased in the TBI group (D) with respect to control group (E), as confirmed in statistical 
analysis (F).
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Figure 6. Immunohistochemical reactions for anti-8OHdG with statistical analysis of the 
immunohistochemical findings and gradation of the reactions. (A) Anti-8OHdG reaction was intensely positive 
mainly in TBI neurons, compared to control group (B), as confirmed in statistical analysis (C).
Figure 7. ROC and AUCs for TBI group and control group. Receiver-operating characteristic (ROC) curves 
were built and the areas under the curve (AUCs) were calculated for each miRNA differently expressed in brain 
sections of subjects who died for traumatic brain injury and control group.
www.nature.com/scientificreports/
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damage, inhibiting neuronal apoptosis and promoting angiogenesis40. So far, the overexpression of miR-21 has 
been described in biological fluids from subjects with brain injury. For example, a recent study by Illerhaus and 
Batchelor found elevated levels of miR-21 in cerebrospinal fluids from 23 primary CNS lymphoma (PCNSL) 
patients compared to 30 controls41.
An increase in basal expression of miR-21 was observed in aged mice brain compared to adult counterpart. 
The increase in miR-21 levels following TBI has been reported in the adult mice, with a maximum peak 24 hours 
after injury. On the contrary, miR-21 levels decreased after TBI in the aged mice42. Furthermore, a downregu-
lation in miR-21 levels has been reported by Nelson et al. on snap-frozen white versus grey matter tissue from 
Alzheimer’s patients43. It is worth noting that a proper comparison between our and other reports cannot be 
made, in terms of starting material and experimental conditions. Nonetheless, similarly to what has been said for 
miR-21, miR-92 and miR-16, in our cases we observed a decrease in expression in traumatic brain injury cases 
with respect to controls. In fact, their expression in controls was three times higher than subjects who died for 
traumatic brain injury. In accordance with our results, a study performed by Redell et al. explored plasma miRNA 
profiles in severe traumatic brain injury patients and healthy volunteers and found decreased levels of miR-16 and 
miR-92, which were demonstrated to behave as good markers of severe TBI at 25–48 h after injury44.
These data indicate that these three miRNAs have a high predictive power in discriminating trauma brain 
cases from controls and could represent promising biomarkers for the diagnosis of postmortem traumatic brain 
injury45.
A field of very promising research in evaluation of brain injury, in addition to the identification of possible 
blood markers useful for the assessment and clinical staging of TBI, is the search for newer immunohistochemical 
markers that may be useful to the pathologist for timing of traumatic brain injury. In fact, currently used markers 
do not always allow to discriminate acute TBI from a sub-acute (<8 h after the traumatic event), because lies in 
the lack of sensitivity in the acute phase if survival time is less of 12 hours for the HE preparation and for detection 
of β-APP with a time that is more of 12 h for silver preparation or CD68. Actually, the main immunohistochemi-
cal markers used for the evaluation of traumatic brain injury include β-APP (β-amyloid precursor) and anti-glial 
fibrillary acid protein (GFAP)46,47.
β-APP is a surface protein that has multiple functions and play an important role in many neuronal intracel-
lular processes48 and can be considered one of the most reliable marker of a diffuse axonal injury. The β-APP has 
proven to be one of the most selective immunohistochemical markers in identifying and diagnosing a diffuse 
axonal injury49,50. In fact, the positive immunohistochemistry for β-APP is not detectable in undamaged brain 
tissue samples, while there has been an increase in immunoreactivity from 2 h after a traumatic brain injury51,52.
More recent studies have also enabled to detect how it is possible to highlight a different immunohistochemi-
cal patterns in β-APP immunoreactivity which may aid in discriminating a traumatic brain injury from one type 
of ischemic type53.
Figure 8. Expression of miR-21, miR-16, and miR-92. Expression of these miRNA was significantly higher in 
controls than subjects who died for traumatic brain injury.
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The immunoreactivity for GFAP and S100 in astrocytic level can be used for the timing of the brain injury 
having been shown that such positivity is significantly lower in subacute cases, or delayed and having Li et al. also 
describes a possible correlation between the severity of trauma and the immunopositivity for GFAP and S10054.
Li et al. have shown that, in rats, serum and CSF levels of GFAP can be considered as potential markers in 
severe or moderate cases of traumatic brain injury, also highlighting a positive correlation between the linear 
acceleration and power of the trauma with serum and CSF levels of these markers.
However GFAP seems to be a better biomarker of mild TBI than is S100-B, because has not been detected 
extracerebral expression of GFAP. Li suggest that GFAP-immunopositivity showed that subacute/delayed death 
cases with a survival period over 12 h after brain injury showed lower astrocyte GFAP-immunopositivity in 
Hyppocampal CA4 region.
Neurofilaments are the main cytoskeletal components in neuronal cells, important for maintaining axonal 
caliber. After axonal cell injury caused by direct trauma increased levels of light neurofilament were observed55.
Spectrin plays important roles in nervous cells, it exhibited periodic structures alternating with those of actin 
and adducin, and the distance between adjacent actin-adducin rings was comparable to the length of a spectrin 
tetramer56,57.
Among the potentially most promising marker for the timing in the acute phase of brain injury covered oxi-
dative stress markers58–61. In this study, we investigated the possible contribution of 8OHdG one of the predom-
inant form of ROS-induced oxidative damage to DNA, which has therefore been widely used as a very reliable 
biomarker for oxidative stress presence. We found that expression of 8OHdG was significantly increased in the 
group of subjects died following TBI, with respect to subjects from control group.
Most of alterations induced by TBI are related with oxidative stress and how widely demonstrated play a very 
important role on TBI sequelae. Oxidative stress is implicated on the pathogenesis of primary damage but also 
have a significant role in secondary injuries evolution62,63.
Oxidative stress, due to increased production of neurotoxic amino acids action, on all the glutamate, in fact 
increases in production of free radicals with a important alteration of neuronal homeostasis64–66. Traumatic insult 
determines in the first instance a considerable increase in the levels of mediators capable of exerting an action on 
excitotoxicity on neuronal structures such as glutamate. This increase is a result of increased release by the dam-
aged cells and as consequence of the increased activities of the astrocytic glutamate transporter. The increased 
activation of glutamate receptors causes an increase of intracellular concentration of calcium that is responsible 
for the induction of different biosynthetic pathways, including NOS pathway. The increased production of NO, 
contextually to high concentration of intracellular of calcium, play a toxic action on mitochondrial function, that 
results in an increased activation of cathepsin with induction of apoptotic pathways. Increased production of free 
radicals highly reactive can also damage DNA, in addition to direct neurotoxic action due to lipoperoxidation and 
consequent neuronal membrane damage25.
Immunohystochemical studies have shown that oxidative stress secondary to trauma leads to increased expo-
sure of the neuronal structures and especially hippocampal cytokines. This increased exposure is reflected on the 
activity of glial cells (astroglia and microglia) that mediate the response to traumatic damage. Turyn et al. have 
shown that there are early time-dependent changes in cellular oxidative markers (GSSG, protein carbonyls, 3-NT, 
4-HNE, and acrolein), the antioxidant system (GSH, GST, GPx, GR, G-6PD, Cu/Zn- or Mn-SOD, and CAT), and 
synaptic proteins (synapsin I, PSD-95, and SAP-97) in the adult rat hippocampus following experimental TBI67.
Frugier et al. analyzed humoral and cellular inflammation elicited after TBI in post mortem human brain tis-
sue and found that pro-inflammatory cytokine protein levels of IL-1β, IL-2, IL-6, IL-8, IFN, TNF-α and GM-CSF 
were significantly increased after an acute brain injury in humans. Same authors have produced a quantitative 
analysis of mRNA levels of several inflammatory mediators, and have found a significantly increased following 
TBI66.
Our results showed that the reaction to IL-1β, although intense, was positive mainly in neurons since the 
acute stages and in neurons but also in glial cells in the following stage (non-acute). In particular, cytokine IL-1β 
positive reaction was observed in neurons only in non-acute cases, associated to vascular and glial positivity. The 
expression in acute cases was shown mainly at vascular level.
Traumatic brain injury often produces neuronal apoptosis as direct effect of trauma or as a consequence of 
hypoxic changes, for increased intracranial pressure or oedema.
Recent studies have shown that apoptosis contributes to neuronal and glial cell loss following both acute neu-
rological disorders and in traumatic brain injuries (TBI) lead to activation of caspases’s pathways, where caspase-3 
play a very important role.
Tao et al. have found that follow a TBI a caspase 3 reaction was detectable in cortical neurons after a 
post-traumatic interval of 80 min from trauma, with a peak level reached after 48 h. The expression of caspase-3 
increased after TBI, reached a peak 24–48 h after TBI, and then decreased. The present results suggest that the 
determination of TUNEL expression could hardly be used to estimate TBI time course unless morphological 
changes of positive cells been considered68.
Conclusions
Proper survival of the clinical course of the Brain Traumatic Injury today still represents a great challenge for the 
clinicians, the considerable implications that proper dating takes in assessing the clinical case. For the pathologist, 
the historical immunohistochemical markers used (β-APP, GFAP) will continue to play an important role in the 
diagnostic evaluation process; the best understanding of the molecular mechanisms involved in the pathogenesis 
of the resulting damage to a TBI, however, and the understanding of oxidative stress leading to apoptosis will 
assume greater importance, as the potential to allow for a more precise diagnosis in time compared to classic 
markers. Difficulty in the use of infiammatory markers such as immunohystochemical markers of TBI in early 
stage, is due to the overlap of secondary changes after traumatic event (es. hypoxia, edema) that can lead to 
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difficult to errors in estimating the survival time. Our data indicate that miR-21, miR-92 and miR-16 have a high 
predictive power in discriminating trauma brain cases from controls and could represent promising biomarkers 
as strong predictor of survival, and usefulness tool for postmortem diagnosis of traumatic brain injury.
Materials and Methods
Clinical study. Between June 2008 and June 2016 a total of 21 patient suffering from severe TBI were admit-
ted at Sant’Andrea Emergency Department - Sapienza University of Rome, and subsequently clinically diagnosed 
with DAI. Diagnosis was performed according to the following clinical and radiological criteria: a coma lasting 
more than 6 hours after a TBI with no space occupying hemorrhagic or ischemic lesion or focal swelling on CT 
scan. In the final cohort, a total of 18 males and 3 females were included.
When clinical conditions were judged to be completely stable, patients underwent elective brain MRI scan. 
On the ground of this MRI scan each patient was classified according to the classification proposed by Gennarelli, 
based on the topographical distribution of the lesions69. A total of 7 patients were diagnosed with DAI grade II, 
1 patient grade I, while a total of 13 patients presented radiological signs of brainstem involvement and therefore 
were classified as grade III. The most common cause of incident was car accident, we recorded 6 motorcycle acci-
dents, 2 precipitated and 2 ran over patients and one patient victim of violence. Sixteen of these patients suffered 
from a multiple trauma rather than just a head trauma.
The average GCS at admission was 4,75 ± 1,64. Physicians of the Post-Acute Rehabilitation centers and fam-
ilies were contacted by phone call, during December 2016, to undergo a simple phone questionnaire inspired to 
Glasgow Outcome Scale (GOS). A total of 10 patients (47,6% of the total) were dead at six months after trauma. 
An adjunctive mortality of 14,28% was recorded at 12 months after trauma. A total of 5 patients (23,08%) were 
alive. Therefore, the average GOS at 6 months, among the survived patients, was 2.54 and overall average survival 
was 16.5 ± 23.07 months.
A total of 14 patients underwent a surgical procedure of ventriculostomy, external shunting. In all of these 
patients the catheter had an ICP sensor in order to monitor intracranial pressure. In 8 of these patients, inten-
sive care physicians were not able to control ICP conservatively and underwent bilateral craniectomy. ICP value 
higher than 20mmH2O not responsive to conservative treatments was considered as a surgical indication to per-
form bilateral decompressive craniectomy.
In 7 patients, at admission GCS was 3, were hemodynamically unstable, pupillary light reflex was obviously 
torpid or patient was midriatic, brain CT scan disclosed obvious brainstem hypodensity and no surgical proce-
dure was performed.
During the first 72 hours of ICU stay, a total of 6 patients were diagnosed with severe hypotension (hypoten-
sion was considered as systolic blood pressure under 90 mmHg despite intravenous injection of inotropic agents). 
Multiple Organ Failure, as a result of systemic inflammation caused by severe infections was recorded in the 3 
months after trauma in 7 patients (33,3%) (Table 2).
Immunohistochemistry study. A total of 26 archived formalin-fixed, paraffin-embedded (FFPE) brain 
tissue blocks were processed in the Department of Anatomical, Histological, Forensic and Orthopedic Sciences 
of Sapienza University of Rome. Of these, 16 were cases of TBI enrolled in the present study with fatal outcome, 
and 10 were control cases (sudden cardiac death). The processing of the data reported in this paper is covered 
by the general authorization to process personal data for scientific research purposes granted by the Italian Data 
Protection Authority (1 March 2012 as published in Italy’s Official Journal no. 72 dated 26 March 2012) since the 
data do not entail any significant personalized impact on data subjects. Our study does not involve the application 
of experimental protocols; therefore it does not require approval by an institutional and/or licensing committee. 
In all cases, local prosecutors opened an investigation, ordering that an autopsy be performed to clarify the exact 
cause of death.
Brain tissues from cases and controls were fixed in 10% buffered formalin for 48 hr. 4 μm-thick 
paraffin-embedded sections were cut and stained with hematoxylin and eosin. In addition, immunohisto-
chemical investigation of the frontal section with the structures of thalamus, hypothalamus, and striatum was 
performed with antibodies β-APP (Novocastra, Newcastle upon Tyne, United Kingdom), GFAP (Santa Cruz, 
CA, USA), IL-1β (Santa Cruz, CA, USA), 8OHdG (1:10, JaICA, Japan), anti-70 kD Neurofilament Light anti-
body (Abcam, Cambridge, UK), AlphaIISpectrin/SPTAN1 polyclonal antibody (Thermo Fischer, IL, USA) and 
TUNEL assays (Chemicon, Temecula, CA). 4-μm-thick paraffin sections were mounted on slides covered with 
3-amminopropyl-triethoxysilan (Fluka, Buchs, Switzerland). A pretreatment was necessary to facilitate antigen 
retrieval and to increase membrane permeability to antibodies: antibody anti-β-APP was boiled in 0.1 M cit-
ric buffer; antibody anti-IL-1β and antibody anti-GFAP were boiled in 0.25 M EDTA buffer. The primary anti-
body was applied in a 1:300 ratio for β-APP, in a 1:4000 ratio for IL-1β and in a 1:500 ratio for GFAP. Primary 
anti-GFAP and anti-IL-1β antibodies were kept at room temperature for 120 min, whereas the incubation of 
primary anti-β-APP antibody was overnight. For TUNEL assay the sections were covered with the TdT enzyme, 
diluted in a ratio of 30% in reaction buffer (Apotag Plus Peroxidase In Situ Apoptosis Detection Kit; Chemicon) 
and incubated for 60 min at 38 °C.
Detection was performed with LSAB1 Kit (Dako, Carpinteria, CA), a refined avidin-biotin technique in which 
a biotinylated secondary antibody reacts with several peroxidase-conjugated streptavidin molecules. The positive 
reaction was visualized by DAB (3,3-diaminobenzidinetetrahydrochloride hydrate) peroxidation according to 
standard methods. Then, the sections were counterstained with Mayer’s hematoxylin, dehydrated and covers-
lipped. Furthermore, retraction balls and amyloid deposits were detected with Congo Red staining kit (Bio – 
Optica Milano, Italia). All samples were observed under light microscopy (Leica DM4000B optical microscope, 
Leica, Cambridge, United Kingdom) and confocal microscopy. Finally, a three-dimensional reconstruction was 
performed (True Confocal Scanner; Leica TCS SPE).
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miRNAs study. RNA Extraction. Total RNA, including miRNAs, was extracted from FFPE tissues using the 
High Pure miRNA isolation kit (Roche Basilea, Switzerland) according to the manufacturer’s instructions. RNA 
concentrations were evaluated wirh Nanodrop (ThermoScientific Darmstadt, Germany).
Reverse Transcription and Quantitative Real-Time PCR. Reverse transcription and quantitative real-time 
PCRs were performed for the following miRNAs: miR-21, miR-92, miR-16 (Table 3). Each sample was 
reverse-transcribed with TaqMan MicroRNA Reverse Trascription Kit (Applied Biosystems Darmstadt, Germany) 
according to the manufacturer’s protocol. Total RNA was converted into cDNA by sequential incubation with 
reverse transcriptase (RT) at 16 °C for 30 min, 42 °C for 30 min, 85 °C for 5 min and 4 °C. The same amount of RNA 
(10 ng) for each sample was added to the RT reaction mix for each miRNA of interest in a total volume of 15 μL of 
RT reaction, as recommended by the manufacturer (Applied Biosystems, Protocol 4367038 Rev. E).
For PCR assays, TaqMan MiRNA Assay (Applied Biosystems, Darmstadt, Germany) were used. RT-qPCR 
was performed with Stratagene Mx3005p Real-Time PCR equipment with 96-well optical reaction plates. PCR 
reaction mixture (total volume 20 μL) contained 1.33 mL of RT product, 10 μL of TaqMan 2× Universal PCR 
Master Mix and 1 μL of the specific TaqMan MicroRNA Assay (20×) containing probes for the miRNA of interest 
(Applied Biosystems, Darmstadt, Germany). The mixture was initially incubated at 95 °C for 10 min, followed by 
40 cycles of 95 °C for 15 seconds and 60 °C for 60 seconds. Samples were run in duplicate and results were aver-
aged RNU48 (U48) was used to normalize data. The relative miRNA expression was calculated using the 2−ΔCt 
method.
Statistical analysis. Pearson’s Bivariate correlation was used to investigate statistical association between 
continuous and ordinal variable. GCS at admission disclosed strong associations with GOS at six months and sur-


































1 M 52 2 7 3 Moto accident Mainly Head Craniectomy No No Alive (35)
2 M 16 2 6 2 Car accident Multiple Trauma Shunting No No Alive (54)
3 M 28 2 5 2 Violence Multiple Trauma Craniectomy No No 9 + +
4 M 39 3 5 2 Car accident Multiple Trauma Craniectomy Yes No 14 + +
5 M 34 2 8 1 Car accident Mainly Head Shunting No No 4 + +
6 F 54 3 3 1 Car accident Multiple Trauma No Yes Yes 0.1 + +
7 M 25 3 4 1 Moto accident Multiple Trauma Shunting Yes No 0.5 + +
8 M 69 3 3 1 Car accident Multiple Trauma No No Yes 2 + +
9 M 37 2 4 2 Car accident Multiple Trauma No No No Alive (84)
10 M 46 3 3 2 Ran over Mainly Head Shunting No No 8 + +
11 M 50 1 7 4 Car accident Multiple Trauma Craniectomy No No Alive (24)
12 M 72 3 3 1 Precipitation Mainly Head No Yes Yes 0.1 + +
13 M 49 3 4 2 Moto accident Multiple Trauma Craniectomy No No 11 + +
14 M 31 3 5 3 Ran over Multiple Trauma Craniectomy No No 18 + +
15 M 44 3 5 1 Car accident Multiple Trauma Shunting Yes No 3 + +
16 F 36 2 3 1 Car accident Multiple Trauma No No Yes 6 + +
17 M 56 3 5 1 Precipitation Multiple Trauma No Yes Yes 0.5 + +
18 M 25 3 5 3 Moto accident Multiple Trauma No No No 12 + +
19 M 32 3 3 1 Car accident Multiple Trauma Shunting Yes No 0.5 + +
20 F 19 3 4 1 Moto accident Multiple Trauma Craniectomy No Yes 1 + +
21 M 15 2 8 4 Moto accident Mainly Head Craniectomy No No Alive (60)
Table 2. Clinical data of 21 patient suffering from severe TBI, and subsequently clinically diagnosed with DAI.
miRNA name Identification Accession number Primers sequence
miR-21-5p hsa-miR-21 MIMAT0000076 tagcttatcagactgatgttga
miR-92a-3p hsa-miR-92 MIMAT0000092 tattgcacttgtcccggcctgt
miR-16-5p hsa-miR-16 MIMAT0000069 tagcagcacgtaaatattggcg
Table 3. miRNAs sequences used for reverse transcription and quantitative real-time PCR. Sequences were 
reviewed on miRNA database70,71 at http://www.mirbase.org.
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(r = −0.541, p.011). Similarly, DAI grade was negatively associated to with survival (r = −0.616, p.003). GOS at 
six months was associated to survival (r = 0.856, p.0001), demonstrating that a better neurological outcome is 
more likely to be expressed to a long terminal surviving patient.
Data were expressed as the mean ± SD from at least three independent experiments. Statistical analysis was 
performed using Student’s t-test. The diagnostic evaluation of miR-21, miR-92 and miR-16 was performed 
through receiver operating characteristic (ROC) analysis. Areas under the curve (AUCs) were calculated. All sta-
tistical analyses were performed using Graph Pad Prism software (Graph Pad software). p < 0.05 was considered 
statistically significant.
Approval, accordance and ethical statement. Institutional Ethics Committee of Sapienza University 
of Rome, expressed favorable opinion for this study. Clinical and radiological data reported are completely 
anonymized. Our work is coherent with the ethical standards proposed in the Helsinki declaration.
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